Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3
帕博西尼联合内分泌治疗对激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者亚组化疗时间的影响：PALOMA-2和PALOMA-3研究的事后分析
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2022.11.005
Rugo, Hope S; Im, Seock-Ah; Joy, Anil A; Shparyk, Yaroslav; Walshe, Janice M; Sleckman, Bethany; Loi, Sherene; Theall, Kathy Puyana; Kim, Sindy; Huang, Xin; Bananis, Eustratios; Mahtani, Reshma; Finn, Richard S; Diéras, Véronique
